Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation
- PMID: 7365890
- DOI: 10.1016/s0022-5347(17)56001-2
Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation
Abstract
The urine of normal persons, as well as that of stone formers, contains inhibitors to crystallization of calcium oxalate. To ascertain differences, if any, between these 2 groups we measured nucleation rate, growth rate and total mass produced in an analytic system with 5 per cent urine added to 95 per cent synthetic urine that did not contain large organic molecules. We also observed the effects of addition of uromucoid to the synthetic solution. Normal urine and stone-forming urine contained significant inhibitors to total mass of calcium oxalate dihydrate crystals precipitated but total crystal mass was not significantly different between the 2 groups. Growth rate was significantly less in experiments with the urine of stone formers. The other major difference found in stone-forming urine was significant enhancement of nucleation rate when compared to normal urine. Since addition of uromucoid produced these same growth inhibition and nucleation enhancement effects but did not affect total crystal mass, we hypothesize that uromucoid has an important part in producing the differences noted between and stone-forming urine.
Similar articles
-
Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation.Trans Am Assoc Genitourin Surg. 1979;71:62-6. Trans Am Assoc Genitourin Surg. 1979. PMID: 161827
-
Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x. Kidney Int. 1999. PMID: 10231440
-
Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.Clin Chim Acta. 1995 Jul 31;239(1):1-11. doi: 10.1016/0009-8981(95)06092-r. Clin Chim Acta. 1995. PMID: 7586581
-
Glycoprotein calcium oxalate crystal growth inhibitor in urine.Miner Electrolyte Metab. 1987;13(4):267-72. Miner Electrolyte Metab. 1987. PMID: 3306319 Review.
-
Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.Scanning Microsc. 1995 Jun;9(2):597-614; discussion 614-6. Scanning Microsc. 1995. PMID: 8714752 Review.
Cited by
-
In vitro calcium oxalate crystallisation methods.Urol Res. 2006 Apr;34(2):139-45. doi: 10.1007/s00240-005-0027-z. Epub 2006 Jan 14. Urol Res. 2006. PMID: 16416112 Review.
-
The paradox of inhibition and enhancement of the formation of urinary stones.Urol Res. 1982;10(4):165-8. doi: 10.1007/BF00255938. Urol Res. 1982. PMID: 6184871
-
Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro.Urol Res. 1995;23(1):53-62. doi: 10.1007/BF00298852. Urol Res. 1995. PMID: 7618236
-
The effect of serum on the crystallization of calcium oxalate in whole human urine: inhibition disguised as apparent promotion.Urol Res. 1987;15(2):87-92. doi: 10.1007/BF00260939. Urol Res. 1987. PMID: 3590435
-
The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription.World J Urol. 1993;11(1):59-65. doi: 10.1007/BF00182173. World J Urol. 1993. PMID: 8490669 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources